143 related articles for article (PubMed ID: 10347750)
1. Regulation of transgene expression in genetic immunization.
Harms JS; Oliveira SC; Splitter GA
Braz J Med Biol Res; 1999 Feb; 32(2):155-62. PubMed ID: 10347750
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter.
Harms JS; Splitter GA
Hum Gene Ther; 1995 Oct; 6(10):1291-7. PubMed ID: 8590733
[TBL] [Abstract][Full Text] [Related]
3. Optimization of transcriptional regulatory elements for constructing plasmid vectors.
Xu ZL; Mizuguchi H; Ishii-Watabe A; Uchida E; Mayumi T; Hayakawa T
Gene; 2001 Jul; 272(1-2):149-56. PubMed ID: 11470520
[TBL] [Abstract][Full Text] [Related]
4. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
[TBL] [Abstract][Full Text] [Related]
5. [Effects of Different Promoters and
Li Q; Wang XY; Zhao CP; Tian ZW; Xu DH; Wang TY; Zhang JH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):18-23. PubMed ID: 29737083
[TBL] [Abstract][Full Text] [Related]
6. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.
Qin L; Ding Y; Pahud DR; Chang E; Imperiale MJ; Bromberg JS
Hum Gene Ther; 1997 Nov; 8(17):2019-29. PubMed ID: 9414251
[TBL] [Abstract][Full Text] [Related]
7. Comparison of CMV, RSV, SV40 viral and Vlambda1 cellular promoters in B and T lymphoid and non-lymphoid cell lines.
Zarrin AA; Malkin L; Fong I; Luk KD; Ghose A; Berinstein NL
Biochim Biophys Acta; 1999 Jul; 1446(1-2):135-9. PubMed ID: 10395926
[TBL] [Abstract][Full Text] [Related]
8. A self-augmenting gene expression cassette for enhanced and sustained transgene expression in the presence of proinflammatory cytokines.
Luo P; Reed BD; Tsang TC; Harris DT; Flavell RA
DNA Cell Biol; 2006 Dec; 25(12):659-67. PubMed ID: 17184167
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
10. Silencing of fat-1 transgene expression in sheep may result from hypermethylation of its driven cytomegalovirus (CMV) promoter.
Duan B; Cheng L; Gao Y; Yin FX; Su GH; Shen QY; Liu K; Hu X; Liu X; Li GP
Theriogenology; 2012 Sep; 78(4):793-802. PubMed ID: 22541322
[TBL] [Abstract][Full Text] [Related]
11. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
12. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
13. DNA immunization using a non-viral promoter.
Vanniasinkam T; Reddy ST; Ertl HC
Virology; 2006 Jan; 344(2):412-20. PubMed ID: 16226783
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.
Konopka K; Spain C; Yen A; Overlid N; Gebremedhin S; Düzgüneş N
Cell Mol Biol Lett; 2009; 14(1):70-89. PubMed ID: 18839071
[TBL] [Abstract][Full Text] [Related]
15. Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector.
Xu ZL; Mizuguchi H; Ishii-Watabe A; Uchida E; Mayumi T; Hayakawa T
J Control Release; 2002 May; 81(1-2):155-63. PubMed ID: 11992688
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
17. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
Addison CL; Hitt M; Kunsken D; Graham FL
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
[TBL] [Abstract][Full Text] [Related]
19. Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors.
Shi CX; Hitt M; Ng P; Graham FL
Hum Gene Ther; 2002 Jan; 13(2):211-24. PubMed ID: 11812278
[TBL] [Abstract][Full Text] [Related]
20. The EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells.
Wang X; Xu Z; Tian Z; Zhang X; Xu D; Li Q; Zhang J; Wang T
J Cell Mol Med; 2017 Nov; 21(11):3044-3054. PubMed ID: 28557288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
